Search

everythinglearnresearchcommunity

for

Search:↓

Post-finasteride patients show changed neuroactive steroid levels, possibly causing erectile dysfunction and depression.

Melatonin and mitotane treatment led to hair re-growth in 62% of dogs with Alopecia X, but this was not always linked to normal hormone levels.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Using β-cyclodextrin derivatives improves the solubility and bioavailability of steroidal drugs.

Neuroactive steroids show promise for treating mental and neurological disorders by targeting GABA_A receptors.

Intralesional steroids can help regrow hair in some alopecia areata patients but have side effects.

Men and women have different levels and production of brain steroids, which may affect their risk for certain brain disorders.

Finasteride treatment changes brain steroid levels and receptors, affecting brain function even after stopping treatment.

Neuroactive steroids could become safe, effective treatments with more understanding of their complex brain actions and metabolism.

Late puberty may slightly lower prostate cancer risk, baldness is not linked to overall risk but less so with aggressive types, ibuprofen use may increase risk, and vitamins show no effect on risk.

Benzo[c]quinolizin-3-ones are effective nonsteroidal inhibitors of human steroid 5α-reductase 1.

Neuroactive steroids and the enzyme 5α-reductase might be involved in the development of Tourette's syndrome.

Anabolic steroid users may face higher risk of severe COVID-19.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Some steroid-induced health issues in rodents improved after stopping treatment, but hair loss and eye problems did not.

Scientists found new, better-working inhibitors for a hormone-related enzyme.

Women with hair loss had higher levels of certain hormones, suggesting a link to a condition like PCOS.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

Inhaled steroids in children may cause excessive hair growth and not always go away after stopping the medication.

Men with male-pattern baldness have higher levels of certain testosterone metabolites and may have more active androgen metabolism.

Gut microbes significantly affect brain steroid levels.

Male C57BL/6 mice show age-related fluctuations in certain hormones and their ratios in both blood and hair.

Sex steroids, especially progesterone, can slow down the growth of mouse melanoma cells.

Bolandiol, a synthetic steroid, builds muscle and bone without greatly affecting sex glands, and works differently from other hormones.

Testosterone makes the connections in the uterus lining simpler and lowers certain protein levels, which might lead to infertility.

Korean and Caucasian men with male pattern baldness have different hair steroid levels.

Dogs with sex hormone imbalances may not drink or pee a lot but often lose hair on their body and can have reproductive system issues.

RU58841 significantly increases hair growth rate and initiates more hair cycles, but doesn't affect hair thickness, suggesting it could be a new treatment for baldness.

Combining cetirizine and topical steroids can effectively manage severe lichen planus pilaris.

Finasteride treatment can decrease certain steroids and increase others, possibly leading to depression symptoms in some cases.